F Farace

A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas

F Farace, Christophe Massard, Nadège Vimond et al. · British Journal of Cancer · 2011 · 399 citations · Full text

Medicine, Cell Biology, Oncology +15

High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer

Emma Pailler, Nathalie Auger, Colin R. Lindsay et al. · Annals of Oncology · 2015 · 118 citations · Full text

Medicine, Genetics, Oncology +17

Immunotherapy with lymphokine-activated natural killer cells and recombinant interleukin-2: a feasibility trial in metastatic renal cell carcinoma.

Thierry Hercend, F Farace, D Baume et al. · PubMed · 1990 · 58 citations

Life Sciences, Immunology, Oncology +15

Immunotherapy with interleukin-2 (IL2) and lymphokine-activated natural killer cells: Improvement of clinical responses in metastatic renal cell carcinoma patients previously treated with IL2

Bernard Escudier, F Farace, Eric Angevin et al. · European Journal of Cancer · 1994 · 54 citations

Life Sciences, Immunology, Oncology +16

Combination of interleukin-2 and gamma interferon in metastatic renal cell carcinoma

Bernard Escudier, S. Antoun, B. Leclercq et al. · European Journal of Cancer · 1993 · 22 citations

Medicine, Cancer Biology, Oncology +14